Patient reported outcomes in oncology: changing perspectives-a systematic review.

Patient reported outcomes in oncology: changing perspectives-a systematic review.
复制标题

DOI:
10.1186/s12955-022-01987-x
复制
发表时间:
2022-05-21
影响因子:
3.6
通讯作者:
Ferreira, Pedro Lopes
Ferreira, Pedro Lopes
中科院分区:
医学3区
文献类型:
--
作者:
Silveira, Augusta;Sequeira, Teresa;Goncalves, Joaquim;Ferreira, Pedro Lopes

文献摘要

参考文献

被引文献

相似文献

In public health context, oncology is associated with severe negative impact on patients and on their relatives’ quality of life. Over the last decades, survival has remained at 50% worldwide for some tumor locations. Patient reported outcomes (PROs) assessment and, the corresponding use in clinical practice, help establishing patient individualized profiling involving caregivers. The purpose of this systematic review was to examine critical success factors for PROs assessment in daily clinical oncology practice. Additionally, we investigated how PROs collection can change oncology perspectives for patients and caregivers. According to PRISMA guidelines, 83 studies were included in this systematic review, whether related with implementation in daily clinical practice or associated with its use in oncology. PROs assessment gathers multi-professional teams, biomedical and clinical expertise, patients, families and caregivers. Institutional involvement, first line for caregiver’s adherence, team continuous formation, encompassing training and support, design of clear workflows, continuous monitoring, and data analysis are crucial for implementation. PROs measures are decisive in oncology. Several items were improved, including caregiver–patient–physician communication, patient risk groups identification, unmet problems and needs detection, disease course and treatment tracking, prognostic markers, cost-effectiveness measurement and comfort/support provision for both patients and caregivers. Routine assessment and implementation of PROs in clinical practice are a major challenge and a paradigm transformation for future. The online version contains supplementary material available at 10.1186/s12955-022-01987-x.
DOI: 10.1017/s147895151700058x
发表时间: 2018-08-01
影响因子: 2.2
作者:
Bainbridge, Daryl;Giruparajah, Mohanna;Seow, Hsien
通讯作者: Seow, Hsien
DOI: 10.1007/s11136-013-0356-2
发表时间: 2013-10-01
影响因子: 3.5
作者:
Barney, Bradley J.;Wang, Xin Shelley;Mendoza, Tito R.
通讯作者: Mendoza, Tito R.
DOI: 10.1016/j.ejon.2020.101828
发表时间: 2020-12-01
影响因子: 2.8
作者:
Carmel, Sara;Singer, Yoram;Bachner, Yaacov G.
通讯作者: Bachner, Yaacov G.
DOI: 10.3332/ecancer.2017.779
发表时间: 2017-11-10
影响因子: 1.8
作者:
Agarwal, Jai Prakash;Chakraborty, Santam;Badhe, Rupali
通讯作者: Badhe, Rupali
DOI: 10.3390/cancers12123502
发表时间: 2020-11-24
期刊: Cancers
影响因子: 5.2
作者:
Coomans MB;Peeters MCM;Koekkoek JAF;Schoones JW;Reijneveld J;Taphoorn MJB;Dirven L
通讯作者: Dirven L